Strong Balance Sheet and Liquidity
Cash of $12.5 million and no debt at quarter end, providing financial flexibility; generated $5.5 million of cash from operations in first nine months of fiscal 2026.
We use cookies to improve your experience, analyze site usage, and show relevant ads. Go to our Privacy Policy for details.
The call communicated a mixed picture: meaningful near-term financial headwinds with a 25.2% revenue decline, reduced profitability, and lower cash flow are offset by solid liquidity (no debt and $12.5M cash), active shareholder returns (buybacks and increased dividend), a newly granted patent, strategic acquisition (LoveBiome/P84), investments in Shopify and digital infrastructure, stronger field engagement initiatives (Momentum Academy and VIP program), and the appointment of an experienced incoming CEO. Management acknowledged recent underperformance and outlined concrete initiatives to restore growth and operational improvement.
Management said it now expects to finish fiscal 2026 with revenue, adjusted EBITDA and adjusted diluted EPS close to the lower end of its previously issued guidance range; Q3 metrics included revenue of $43.7M (down 25.2% YoY), gross profit 79.0% (79.4% adjusted excluding a $183K MINDBODY allowance), adjusted EBITDA $3.2M (7.3% of revenue) versus $6.4M (11%) prior year, GAAP net income $1.4M ($0.11/diluted) and adjusted net income $1.5M ($0.12), commissions and incentive expense expected to be ~42.5% of revenue for the full year, SG&A $13.9M (31.7% of revenue), income tax $0.3M in Q3 with a fiscal 2026 effective tax rate guidance of ~18–20%, cash of $12.5M and no debt, cash from operations $5.5M for the first nine months (about $5M in Q3 and expected to be similar in Q4), capital expenditures $2.5M YTD with roughly $1M in the March quarter and near-term spend tied to the Shopify rollout before declining, $3.7M cash used for the LoveBiome acquisition, 206K shares repurchased for ~$1.0M in the quarter (250K/$1.6M YTD) with $59M remaining on a $60M buyback authorization, and a quarterly cash dividend of $0.05 per share (an 11% increase) payable 06/15/2026 to holders of record 06/01/2026.
Cash of $12.5 million and no debt at quarter end, providing financial flexibility; generated $5.5 million of cash from operations in first nine months of fiscal 2026.
Repurchased ~206k shares for $1.0 million in the quarter and ~250k shares for $1.6 million year-to-date; $59 million remaining on a $60 million share repurchase authorization; announced quarterly cash dividend of $0.05 per share (an 11% increase).
Granted a U.S. patent for the Healthy Glow Essentials Stack (Protandim NRF2 Synergizer + TruScience Liquid Collagen), validating scientific innovation and product differentiation.
Board appointed Terrence Moorhead as incoming CEO (joining in August), bringing over 30 years of leadership and direct-selling experience aimed at accelerating growth.
Closed LoveBiome acquisition (October 2025) and integrated P84 (gut activator) into hero product lineup to broaden offerings and address gut-health trends; $3.7 million cash used for LoveBiome acquisition in the first nine months.
Momentum Academy event showed strong consultant engagement; launched the VIP 12-month volume growth incentive to reward growth and develop leadership pipeline, designed to drive field activation.
Ongoing significant investment to upgrade e-commerce platform with Shopify and back-office systems; capital expenditures of $2.5 million for first nine months (up from $1.2 million prior year) to support digital transformation.
Reported gross profit of 79% (non-GAAP adjusted 79.4% excluding a $183k MINDBODY inventory allowance), indicating relatively high gross margins despite pressure from shipping, warehouse, and inventory obsolescence costs.
Good day, ladies and gentlemen. Welcome to today's conference call to discuss LifeVantage Corporation's 2026 results. At this time, all participants are in a listen-only mode. Following the formal remarks, we will conduct a question-and-answer session. Instructions will be provided at that time for you to queue up. Hosting today's conference will be Reed Anderson with ICR. As a reminder, today's conference is being recorded. And now I would like to turn the conference over to Mr.
Anderson. Please go ahead, sir.
Thank you. Good afternoon, and welcome to LifeVantage Corporation's conference call to discuss results for 2026. On the call today from LifeVantage Corporation are Michael Beindorff, Interim Chief Executive Officer; Carl Aure, Chief Financial Officer; and Kristen Cunningham, Chief Sales Officer. By now, everyone should have access to the earnings release, which went out this afternoon at approximately 4:05 p.m. Eastern Time. If you have not received the release, it is available on the Investor Relations portion of LifeVantage Corporation's website at lifevantage.com. This call is being webcast, and a replay will be available on the company's website as well. Before we begin, we would like to remind everyone that our prepared remarks contain forward-looking statements, and management may make additional forward-looking statements in response to your questions.
These statements do not guarantee future performance, and therefore, undue reliance should not be placed upon them. These statements are based on current expectations of the company's management and involve inhe...
May 6th, 2026
February 4th, 2026
November 4th, 2025
September 4th, 2025
May 6th, 2025
February 5th, 2025
October 29th, 2024
August 28th, 2024
May 2nd, 2024
January 30th, 2024
November 9th, 2023
August 28th, 2023